Trust CO Of Vermont Pfizer Inc Transaction History

Trust CO Of Vermont

$2.01 Billion
Q4 2024

A detailed history of Trust CO Of Vermont transactions in Pfizer Inc stock. As of the latest transaction made, Trust CO Of Vermont holds 323,516 shares of PFE stock, worth $8.37 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares

323,516

Previous 408,123 20.73%

Holding current value

$8.37 Million

Previous $11.8 Million 27.34%

% of portfolio

0.43%

Previous 0.6%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 15, 2025	SELL	$24.8 - $30.19 $2.1 Million - $2.55 Million	-84,607 Reduced 20.73%	323,516 $8.58 Million
Q3 2024 Oct 16, 2024	BUY	$27.7 - $31.39 $172,931 - $195,967	6,243 Added 1.55%	408,123 $11.8 Million
Q2 2024 Jul 09, 2024	BUY	$25.26 - $29.6 $367,634 - $430,798	14,554 Added 3.76%	401,880 $11.2 Million
Q1 2024 May 03, 2024	BUY	$25.89 - $29.73 $1.75 Million - $2.01 Million	67,617 Added 21.15%	387,326 $10.7 Million
Q4 2023 Mar 08, 2024	SELL	$26.13 - $33.94 $1.3 Million - $1.69 Million	-49,871 Reduced 13.49%	319,709 $9.2 Million
Q3 2023 Nov 27, 2023	BUY	$32.09 - $37.51 $948,131 - $1.11 Million	29,546 Added 8.69%	369,580 $12.3 Million
Q2 2023 Jul 17, 2023	BUY	$36.12 - $41.79 $1.17 Million - $1.35 Million	32,254 Added 10.48%	340,034 $12.5 Million
Q1 2023 Apr 07, 2023	BUY	$39.39 - $51.28 $545,196 - $709,766	13,841 Added 4.71%	307,780 $12.6 Million
Q4 2022 Feb 09, 2023	BUY	$41.75 - $54.5 $329,282 - $429,841	7,887 Added 2.76%	293,939 $15.1 Million
Q3 2022 Oct 24, 2022	BUY	$43.76 - $53.42 $113,294 - $138,304	2,589 Added 0.91%	286,052 $12.5 Million
Q2 2022 Jul 20, 2022	SELL	$46.53 - $55.17 $467,300 - $554,072	-10,043 Reduced 3.42%	283,463 $14.9 Million
Q1 2022 Apr 05, 2022	SELL	$45.75 - $56.69 $561,032 - $695,189	-12,263 Reduced 4.01%	293,506 $15.2 Million
Q4 2021 Jan 21, 2022	BUY	$41.32 - $61.25 $652,856 - $967,750	15,800 Added 5.45%	305,769 $18.1 Million
Q3 2021 Oct 22, 2021	SELL	$39.25 - $50.42 $185,103 - $237,780	-4,716 Reduced 1.6%	289,969 $12.5 Million
Q2 2021 Jul 15, 2021	BUY	$35.91 - $40.68 $446,325 - $505,611	12,429 Added 4.4%	294,685 $11.5 Million
Q1 2021 Apr 16, 2021	BUY	$33.49 - $37.77 $353,553 - $398,737	10,557 Added 3.89%	282,256 $10.2 Million
Q4 2020 Feb 03, 2021	BUY	$33.47 - $42.56 $579,031 - $736,288	17,300 Added 6.8%	271,699 $10 Million
Q3 2020 Nov 06, 2020	BUY	$31.75 - $37.25 $424,973 - $498,591	13,385 Added 5.55%	254,399 $9.34 Million
Q2 2020 Jul 17, 2020	SELL	$30.12 - $36.54 $1.39 Million - $1.69 Million	-46,192 Reduced 16.08%	241,014 $7.88 Million
Q1 2020 Apr 24, 2020	BUY	$27.03 - $38.62 $342,578 - $489,469	12,674 Added 4.62%	287,206 $9.37 Million
Q4 2019 Feb 06, 2020	BUY	$32.92 - $37.36 $232,184 - $263,500	7,053 Added 2.64%	274,532 $10.8 Million
Q3 2019 Oct 24, 2019	SELL	$32.49 - $42.13 $190,618 - $247,176	-5,867 Reduced 2.15%	267,479 $9.61 Million
Q2 2019 Jul 26, 2019	BUY	$36.98 - $41.52 $48,221 - $54,142	1,304 Added 0.48%	273,346 $11.8 Million
Q1 2019 May 01, 2019	BUY	$37.5 - $41.2 $30,300 - $33,289	808 Added 0.3%	272,042 $11.6 Million
Q4 2018 Jan 30, 2019	SELL	$38.47 - $43.86 $155,918 - $177,764	-4,053 Reduced 1.47%	271,234 $11.8 Million
Q3 2018 Oct 26, 2018	SELL	$34.47 - $41.81 $255,353 - $309,728	-7,408 Reduced 2.62%	275,287 $12.1 Million
Q2 2018 Jul 11, 2018	BUY	$32.98 - $35.16 $443,745 - $473,077	13,455 Added 5.0%	282,695 $10.3 Million
Q1 2018 May 18, 2018	SELL	$31.91 - $37.02 $58,618 - $68,005	-1,837 Reduced 0.68%	269,240 $9.56 Million
Q4 2017 Feb 02, 2018	BUY	$33.26 - $35.29 $534,953 - $567,604	16,084 Added 6.31%	271,077 $9.82 Million
Q3 2017 Oct 24, 2017	BUY	$31.0 - $34.15 $7.9 Million - $8.71 Million	254,993	254,993 $9.1 Million

Others Institutions Holding PFE

# of Institutions

3,228

Shares Held

3.62B

Call Options Held

77.1M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $145B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust CO Of Vermont, based on Form 13F filings with the SEC.

News

Stay updated on Trust CO Of Vermont with notifications on news.

Account

Trust CO Of Vermont Pfizer Inc Transaction History